Delivery Order SPE2DB22D3011-SPE2DB24FP8US
- Not listed
- This federal contract award, valued at $77,864.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA). The $89,483.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 16, 2022 and was awarded on May 13, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which maintains a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA). The $7,146.27 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 18, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $28,926.59 firm fixed-price delivery order is for Gilenya 0.5 mg capsules to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Gilenya 0.5 mg capsules to support medical supply needs. The $19,335.84 firm fixed-price contract was awarded on May 19, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,750.55 firm fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, with a completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $58,626.04, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The firm-fixed-price delivery order, valued at $17,544.05, is for the supply of Gilenya 0.5 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC enables the efficient procurement...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a part of the U.S. Department of Defense (DoD). The contract, valued at $8,002.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication, to support DoD and other government healthcare...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8USDelivery Order
This federal contract award is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $41,942.43, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company, Cencora, Inc., which does business as AmerisourceBergen, also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 1/25/24 |